Suppr超能文献

在一个对甲状腺激素有抵抗的家族中,组织对甲状腺激素的反应,该家族携带甲状腺激素受体β基因常见突变(P453T)。

Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T).

作者信息

Wu Sharon Y, Sadow Peter M, Refetoff Samuel, Weiss Roy E

机构信息

Department of Medicine, The University of Chicago, Chicago, Illinois 60645, USA.

出版信息

J Lab Clin Med. 2005 Aug;146(2):85-94. doi: 10.1016/j.lab.2005.04.005.

Abstract

Resistance to thyroid hormone (RTH) is a dominantly inherited syndrome of reduced tissue responsiveness to thyroid hormone (TH) usually due to mutations in the TH receptor beta gene (TRbeta). We studied pituitary and peripheral tissue responses to graded doses of liothyronine (L-T3) in 5 affected members (2 children and 3 adults) of a family with RTH due to the common TRbeta mutation P453T. Overall, the 5 subjects studied exhibited suppressed thyrotropin response to thyrotropin-releasing hormone of 51% +/- 8%, 12.1% +/- 1.5%, and 6.3% +/- 3% of the 100% baseline on 50, 100, and 200 microg/dL L-T3, respectively. This degree of suppression was greater than that observed in subjects with RTH due to other TRbeta mutations, indicating less resistance. Compared with normal subjects, however, the family described here demonstrated less suppression by L-T3, compatible with their RTH, although of a mild magnitude. The 2 children with RTH demonstrated less L-T3-mediated suppression of prolactin and cholesterol than the adults. Patients often receive thyroid ablative therapy before the diagnosis of RTH and are left with variable degrees of hypothyroidism. Our results demonstrate that graded doses of L-T3 can be used to evaluate RTH patients, even under the condition of limited thyroid reserve, when results are compared with their baseline. We demonstrate that RTH patients can be evaluated either on or off thyroid hormone and still be distinguished from hypothyroid subjects without RTH.

摘要

甲状腺激素抵抗(RTH)是一种常染色体显性遗传综合征,其特征为组织对甲状腺激素(TH)的反应性降低,通常是由于甲状腺激素受体β基因(TRbeta)发生突变所致。我们研究了一个因常见TRbeta突变P453T而患RTH的家族中5名受累成员(2名儿童和3名成人)对不同剂量碘塞罗宁(L-T3)的垂体和外周组织反应。总体而言,在50、100和200μg/dL的L-T3水平下,这5名受试者对促甲状腺激素释放激素的促甲状腺激素反应分别被抑制至100%基线水平的51%±8%、12.1%±1.5%和6.3%±3%。这种抑制程度大于因其他TRbeta突变而患RTH的受试者,表明抵抗程度较低。然而与正常受试者相比,本文所述家族受L-T3的抑制作用较小,这与其轻度的RTH相符。两名患RTH的儿童受L-T3介导的催乳素和胆固醇抑制作用比成人小。患者在RTH诊断之前常接受甲状腺消融治疗,之后会遗留不同程度的甲状腺功能减退。我们的结果表明,当与基线结果相比较时,即使在甲状腺储备有限的情况下,不同剂量的L-T3也可用于评估RTH患者。我们证明,RTH患者无论在甲状腺激素治疗期间还是停药后均可进行评估,且仍可与无RTH的甲状腺功能减退受试者区分开来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验